
Sifting Through Senior-Loken Syndrome 9: Genetic Testing as a Guiding Light
Rare Senior-Loken syndrome 9 impacts kidneys and eyes. Genetic testing aids diagnosis, management, family planning, and personalized treatment strategies.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Rare Senior-Loken syndrome 9 impacts kidneys and eyes. Genetic testing aids diagnosis, management, family planning, and personalized treatment strategies.

Explore the impact of genetic testing on diagnosing and managing severe hypotonia, psychomotor delays, strabismus, and cardiac defects. Discover personalized care solutions.

Explore the complexities of Severe Intellectual Disability-Corpus Callosum Agenesis and how genetic testing aids early diagnosis, management, and family planning.

Explore how genetic testing reveals the causes of Sideroblastic Anemia 3, enhancing diagnosis and personalized treatment strategies for better patient outcomes.

Unravel rare SOCDHSWMLS with genetic testing. Discover personalized diagnosis, targeted treatments, and family planning options for improved care and outcomes.

Unlock the potential of genetic testing in diagnosing rare skin creases like CSCSC2, enhancing early diagnosis, personalized care, family planning, and research.

Unlock the potential of genetic testing in early diagnosis, tailored treatments, and family planning for SLC39A8-CDG, a complex neurological genetic disorder.

Explore how genetic testing aids in diagnosing Spastic Paraplegia Syndrome, leading to early intervention, personalized treatments, and informed family planning decisions.